Filter
6931
Filtered Results: 6931
Text search:
health
care
products
Featured
Recommendations
712
New Publications
1882
Language
Document type
No document type
3687
Studies & Reports
1151
Guidelines
990
Manuals
409
Strategic & Response Plan
277
Fact sheets
171
Training Material
125
Situation Updates
63
Infographics
21
Resource Platforms
18
Brochures
14
Online Courses
4
App
1
Countries / Regions
Global
301
India
278
Kenya
194
Sierra Leone
139
Ethiopia
137
South Africa
133
Nigeria
132
Western and Central Europe
126
Liberia
124
Nepal
116
Uganda
107
Latin America and the Carribbean
104
Myanmar / Burma
95
Malawi
94
Ghana
88
Rwanda
88
Africa
86
Tanzania
85
Ukraine
83
Zambia
81
Bangladesh
79
Syria
74
Philippines
64
Namibia
55
South–East Asia Region
52
Congo, Democratic Republic of
49
Zimbabwe
43
Eastern Europe
43
Haiti
41
Guinea
40
West and Central Africa
39
Asia
38
East and Southern Africa
36
Lesotho
35
Cambodia
35
Indonesia
35
Mozambique
34
South Sudan
33
Senegal
31
Eastern Europe and Central Asia
31
Russia
31
Middle East and North Africa
28
Burkina Faso
24
Yemen
24
Eswatini/ Swaziland
24
Pakistan
23
Venezuela
22
Brazil
20
Cameroon
19
Germany
19
Botswana
19
Sudan
17
Afghanistan
15
USA
15
Jordan
14
Western Pacific Region
14
Benin
13
Moldova
13
Central African Republic
13
Colombia
12
Vietnam
12
China
11
Lebanon
11
Mali
11
Madagascar
11
Thailand
10
Côte d’Ivoire / Ivory Coast
10
Somalia
10
Tajikistan
9
Turkey
9
Albania
9
Peru
8
Georgia
8
North Macedonia
7
Iran
7
Iraq
7
Ecuador
7
Laos
6
Kyrgyzstan
6
Paraguay
6
North America
6
United Kingdom
6
Argentina
6
Serbia
5
Kazakhstan
5
Southern Africa
5
Papua New Guinea
5
Sri Lanka
5
Egypt
5
Poland
5
Chad
5
Bhutan
5
Timor Leste/ East Timor
4
Chile
4
Saudi Arabia
4
Japan
4
Spain
4
Romania
4
Palestine
4
Fiji
3
Uzbekistan
3
Guinea-Bissau
3
Croatia
3
Hungary
3
Ireland
3
Turkmenistan
3
Mauritius
3
Tunisia
3
Portugal
3
Bolivia
3
Libya
3
North Korea
2
Mexico
2
Gambia
2
Canada
2
Singapore
2
Estonia
2
Niger
2
Burundi
2
Mongolia
2
Qatar
2
Bulgaria
2
Armenia
2
Jamaica
2
Azerbaijan
2
Bosnia and Herzegovina
2
Slovakia
2
Angola
2
Guatemala
2
Switzerland
1
El Salvador
1
Australia
1
Togo
1
Congo-Brazzaville
1
Malaysia
1
Vanuatu
1
Morocco
1
Mauritania
1
Gabon
1
Denmark
1
France
1
Maldives
1
Algeria
1
Morocco
1
Belarus
1
Israel
1
Latvia
1
Djibouti
1
Greece
1
Honduras
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2451
Clinical Guidelines
648
Public Health
424
Women & Child Health
424
Key Resources
349
Capacity Building
133
Pharmacy & Technologies
100
Annual Report MEDBOX
1
Toolboxes
COVID-19
647
HIV
459
Mental Health
417
TB
339
Planetary Health
256
AMR
247
Disability
228
Rapid Response
225
Ebola
211
Caregiver
207
Pharmacy
201
Conflict
188
NTDs
172
NCDs
125
Global Health Education
123
Refugee
105
Natural Hazards
91
Health Financing Toolbox
77
Zika
57
Specific Hazards
54
Cholera
49
Polio
30
Social Ethics
26
Typhoon
4
Health Financing
1
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
2017 update
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective tre...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
August 2020.
Essential diagnostic products areconsidered an integral part of UHC, they are an indispensable element for delivery ofservices andare also a requirement for qualitycare. Despite this realization, a review of the UHC pilot in September 2019 es...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Community pharmacists are the health professionals most accessible to the public and are a cornerstone of primary health care. The role of community pharmacists is expanding globally. This report provides an overview of existing components and provisions of the legal and regulatory framework for com...
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
Maternal mortality has fallen significantly in recent years, especially in countries that have emphasized the prevention of its main causes, such as hemorrhagic and infectious complications and hypertension , including in the Region of the Americas. In its final report on the Plan of Action to Accel...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
This updated implementation guidance is intended for all those who set policy for, or offer care to, pregnant women, families and infants: governments; national managers of maternal and child health programmes in general, and of breastfeeding- and BFHI-related programmes in particular; and health-f...
